Zhangzhou Pientzehuang Pharmaceutical., Ltd
Shanghai Stock Exchange:600436.SS
Sector
Industries
Location
Market Cap
USD 16.92 B
Share Price
USD 28.04
Avg Daily Volume
1,873,757
Change (1 day)
0.17%
Change (1 year)
-3.41%
Change (YTD)
-4.54%
Zhangzhou Pientzehuang Pharmaceutical., Ltd Operating Cash Flow for the year ending December 31, 2024: USD 179.93 M
Zhangzhou Pientzehuang Pharmaceutical., Ltd Operating Cash Flow is USD 179.93 M for the year ending December 31, 2024, a -42.11% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Zhangzhou Pientzehuang Pharmaceutical., Ltd Operating Cash Flow for the year ending December 31, 2023 was USD 310.80 M, a -68.79% change year over year.
-
Zhangzhou Pientzehuang Pharmaceutical., Ltd Operating Cash Flow for the year ending December 31, 2022 was USD 995.97 M, a 1,268.99% change year over year.
-
Zhangzhou Pientzehuang Pharmaceutical., Ltd Operating Cash Flow for the year ending December 31, 2021 was USD 72.75 M, a -67.63% change year over year.
-
Zhangzhou Pientzehuang Pharmaceutical., Ltd Operating Cash Flow for the year ending December 31, 2020 was USD 224.76 M, a -277.99% change year over year.
StockViz
Competitors
Johnson & Johnson
USD 172.78
JNJ
-1.04
-0.60%
Galderma Group N
USD 163.27
GALD.SW
+0.10
0.06%
DSM-Firmenich AG
USD 95.93
DSFIR.AS
+0.66
0.69%
Yunnan Baiyao Group Co.,Ltd
USD 7.80
000538.SZ
+0.01
0.17%
Hims & Hers Health, Inc.
USD 47.96
HIMS
-2.02
-4.04%
Dabur India Limited
USD 5.73
DABUR.NS
-0.01
-0.19%
Walgreens Boots Alliance, Inc.
USD 11.87
WBA
+0.01
0.08%
Zhejiang NHU Company Ltd.
USD 3.15
002001.SZ
+0.01
0.34%
AptarGroup, Inc.
USD 139.48
ATR
-0.39
-0.28%
MatsukiyoCocokara & Co.
USD 22.20
3088.T
-0.15
-0.65%
Imeik Technology Development Co.,Ltd.
USD 25.78
300896.SZ
-0.17
-0.67%
Giant Biogene Holding Co., Ltd.
USD 7.65
2367.HK
+0.13
1.79%
IMCD N.V.
USD 109.89
IMCD.AS
+0.12
0.11%
LB Group Co., Ltd.
USD 2.46
002601.SZ
-0.01
-0.39%
Raia Drogasil S.A.
USD 3.25
RADL3.SA
+0.06
1.93%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Johnson & Johnson
USD 172.78
JNJ
-1.04
-0.60%
Galderma Group N
USD 163.27
GALD.SW
+0.10
0.06%
DSM-Firmenich AG
USD 95.93
DSFIR.AS
+0.66
0.69%
Yunnan Baiyao Group Co.,Ltd
USD 7.80
000538.SZ
+0.01
0.17%
Hims & Hers Health, Inc.
USD 47.96
HIMS
-2.02
-4.04%
Dabur India Limited
USD 5.73
DABUR.NS
-0.01
-0.19%
Walgreens Boots Alliance, Inc.
USD 11.87
WBA
+0.01
0.08%
Zhejiang NHU Company Ltd.
USD 3.15
002001.SZ
+0.01
0.34%
AptarGroup, Inc.
USD 139.48
ATR
-0.39
-0.28%
MatsukiyoCocokara & Co.
USD 22.20
3088.T
-0.15
-0.65%
Imeik Technology Development Co.,Ltd.
USD 25.78
300896.SZ
-0.17
-0.67%
Giant Biogene Holding Co., Ltd.
USD 7.65
2367.HK
+0.13
1.79%
IMCD N.V.
USD 109.89
IMCD.AS
+0.12
0.11%
LB Group Co., Ltd.
USD 2.46
002601.SZ
-0.01
-0.39%
Raia Drogasil S.A.
USD 3.25
RADL3.SA
+0.06
1.93%